Inhalable gene therapy and the lung surfactant problem
Kassab G, Doran K, Mo Y, Zheng G Nano Letters DOI: 10.1021/acs.nanolett.3c03547 Lung-targeting RNA-carrying lipid nanoparticles (LNPs) are often intravenously administered and accumulate in the pulmonary endothelium. However, most respiratory diseases are localized in the airway or the alveolar epithelium. Inhalation has been explored as a more direct delivery method,Continue Reading